Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
Table 3
Multivariate analysis of factors associated with OAC use among patients with nonvalvular atrial fibrillation.
Variable
CI
95% confidence interval
value
Age (year)
<50
1.0
50-75
1.8
1.1
2.8
0.01
>75
1.4
0.8
2.3
0.24
Setting of patient enrollment (outpatient vs. inpatient)
1.9
1.5
2.6
<0.001
Current smoking (no vs. yes)
1.7
1.2
2.4
0.004
Cancer (no vs. yes)
1.8
1.0
3.0
0.04
Stroke or systemic embolization (yes vs. no)
1.7
1.1
2.5
0.01
Atrial fibrillation type (nonparoxysmal vs. paroxysmal)
